vs
Protalix BioTherapeutics, Inc.（PLX）与Satellogic Inc.（SATL）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Satellogic Inc.的1.5倍（$9.1M vs $6.2M），Satellogic Inc.净利率更高（488.0% vs -60.3%，领先548.3%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-12.8M）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
Satellogic Inc.是一家专注于对地观测卫星领域的企业，由埃米利亚诺·卡吉曼和杰拉多·里查特于2010年创立，核心业务围绕地球观测卫星的研发与应用展开，为各类行业需求提供卫星遥感相关的数据与解决方案。
PLX vs SATL — 直观对比
营收规模更大
PLX
是对方的1.5倍
$6.2M
净利率更高
SATL
高出548.3%
-60.3%
自由现金流更多
PLX
多$14.4M
$-12.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $6.2M |
| 净利润 | $-5.5M | $30.5M |
| 毛利率 | 49.4% | — |
| 营业利润率 | -51.1% | -114.2% |
| 净利率 | -60.3% | 488.0% |
| 营收同比 | -49.9% | — |
| 净利润同比 | -184.8% | — |
| 每股收益（稀释后） | $-0.06 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXSATL
| Q4 25 | $9.1M | $6.2M | ||
| Q3 25 | $17.9M | $3.6M | ||
| Q2 25 | $15.7M | $4.4M | ||
| Q1 25 | $10.1M | $3.4M | ||
| Q4 24 | $18.2M | — | ||
| Q3 24 | $18.0M | — | ||
| Q2 24 | $13.5M | $3.5M | ||
| Q4 23 | $10.5M | — |
净利润PLXSATL
| Q4 25 | $-5.5M | $30.5M | ||
| Q3 25 | $2.4M | $4.0M | ||
| Q2 25 | $164.0K | $-6.7M | ||
| Q1 25 | $-3.6M | $-32.6M | ||
| Q4 24 | $6.5M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $-2.2M | $-18.1M | ||
| Q4 23 | $-6.0M | — |
毛利率PLXSATL
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | — | ||
| Q2 25 | 62.5% | — | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 78.7% | — | ||
| Q3 24 | 53.4% | — | ||
| Q2 24 | 29.8% | — | ||
| Q4 23 | 15.5% | — |
营业利润率PLXSATL
| Q4 25 | -51.1% | -114.2% | ||
| Q3 25 | 11.9% | -222.5% | ||
| Q2 25 | 7.5% | -141.6% | ||
| Q1 25 | -41.0% | -280.9% | ||
| Q4 24 | 39.6% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | -18.0% | -419.2% | ||
| Q4 23 | -53.5% | — |
净利率PLXSATL
| Q4 25 | -60.3% | 488.0% | ||
| Q3 25 | 13.2% | 109.2% | ||
| Q2 25 | 1.0% | -149.8% | ||
| Q1 25 | -35.8% | -961.9% | ||
| Q4 24 | 35.6% | — | ||
| Q3 24 | 18.0% | — | ||
| Q2 24 | -16.4% | -517.0% | ||
| Q4 23 | -57.6% | — |
每股收益（稀释后）PLXSATL
| Q4 25 | $-0.06 | $0.24 | ||
| Q3 25 | $0.03 | $-0.02 | ||
| Q2 25 | $0.00 | $-0.06 | ||
| Q1 25 | $-0.05 | $-0.34 | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.03 | — | ||
| Q2 24 | $-0.03 | $-0.20 | ||
| Q4 23 | $-0.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $94.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $60.5M |
| 总资产 | $82.3M | $151.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLXSATL
| Q4 25 | $14.7M | $94.4M | ||
| Q3 25 | $13.6M | $28.3M | ||
| Q2 25 | $17.9M | $32.6M | ||
| Q1 25 | $19.5M | $17.7M | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.4M | — | ||
| Q2 24 | $23.4M | $25.6M | ||
| Q4 23 | $23.6M | — |
股东权益PLXSATL
| Q4 25 | $48.2M | $60.5M | ||
| Q3 25 | $52.9M | $-56.9M | ||
| Q2 25 | $49.9M | $-68.1M | ||
| Q1 25 | $45.2M | $-83.1M | ||
| Q4 24 | $43.2M | — | ||
| Q3 24 | $32.4M | — | ||
| Q2 24 | $28.6M | $19.1M | ||
| Q4 23 | $33.6M | — |
总资产PLXSATL
| Q4 25 | $82.3M | $151.3M | ||
| Q3 25 | $82.3M | $70.9M | ||
| Q2 25 | $78.5M | $73.8M | ||
| Q1 25 | $73.9M | $61.4M | ||
| Q4 24 | $73.4M | — | ||
| Q3 24 | $61.6M | — | ||
| Q2 24 | $91.5M | $76.6M | ||
| Q4 23 | $84.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $-9.5M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-12.8M |
| 自由现金流率自由现金流/营收 | 17.8% | -204.9% |
| 资本支出强度资本支出/营收 | 4.4% | 53.6% |
| 现金转化率经营现金流/净利润 | — | -0.31× |
| 过去12个月自由现金流最近4个季度 | $-13.6M | $-34.3M |
8季度趋势，按日历期对齐
经营现金流PLXSATL
| Q4 25 | $2.0M | $-9.5M | ||
| Q3 25 | $-3.7M | $-8.4M | ||
| Q2 25 | $-5.2M | $-4.3M | ||
| Q1 25 | $-5.1M | $-4.7M | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $4.1M | — | ||
| Q2 24 | $-3.6M | — | ||
| Q4 23 | $3.6M | — |
自由现金流PLXSATL
| Q4 25 | $1.6M | $-12.8M | ||
| Q3 25 | $-4.2M | $-9.7M | ||
| Q2 25 | $-5.7M | $-5.1M | ||
| Q1 25 | $-5.4M | $-6.6M | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $-3.8M | — | ||
| Q4 23 | $3.3M | — |
自由现金流率PLXSATL
| Q4 25 | 17.8% | -204.9% | ||
| Q3 25 | -23.7% | -267.2% | ||
| Q2 25 | -36.2% | -115.3% | ||
| Q1 25 | -53.0% | -195.9% | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | -28.1% | — | ||
| Q4 23 | 31.9% | — |
资本支出强度PLXSATL
| Q4 25 | 4.4% | 53.6% | ||
| Q3 25 | 2.8% | 36.8% | ||
| Q2 25 | 2.8% | 17.5% | ||
| Q1 25 | 3.0% | 56.5% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 1.3% | — | ||
| Q4 23 | 2.4% | — |
现金转化率PLXSATL
| Q4 25 | — | -0.31× | ||
| Q3 25 | -1.58× | -2.11× | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
SATL
| Transferred At Point In Time | $5.7M | 91% |
| Other | $547.0K | 9% |
